​
​

Editas Medicine (EDIT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Editas Medicine Revenue Highlights

00

Editas Medicine Revenue by Period

Editas Medicine Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31--22.83%
2021-12-31--71.85%
2020-12-31-341.93%
2019-12-31--35.71%
2018-12-31-132.64%
2017-12-31-126.80%
2016-12-31-271.58%
2015-12-31-100.00%
2014-12-31--

Editas Medicine generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Editas Medicine Revenue by Quarter

DateRevenueChange
2024-09-30--100.00%
2024-06-30--54.80%
2024-03-31--98.11%
2023-12-31-1025.36%
2023-09-30-84.83%
2023-06-30--70.69%
2023-03-31-50.72%
2022-12-31-15461.90%
2022-09-30--99.34%
2022-06-30--6.04%
2022-03-31--45.70%
2021-12-31-101.21%
2021-09-30-1535.09%
2021-06-30--94.17%
2021-03-31--43.09%
2020-12-31--81.83%
2020-09-30-484.62%
2020-06-30-87.82%
2020-03-31--53.41%
2019-12-31-219.23%
2019-09-30-65.15%
2019-06-30-12.61%
2019-03-31--66.19%
2018-12-31--57.86%
2018-09-30-96.95%
2018-06-30-87.73%
2018-03-31-7.09%
2017-12-31--41.63%
2017-09-30-102.84%
2017-06-30-354.11%
2017-03-31--24.05%
2016-12-31--6.65%
2016-09-30--71.61%
2016-06-30-320.87%
2016-03-31-1.64%
2015-12-31-18.21%
2015-09-30-301.20%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31--

Editas Medicine generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Editas Medicine Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VRTXVertex Pharmaceuticals--
BEAMBeam Therapeutics--
CRSPCRISPR Therapeutics--
DNAGinkgo Bioworks--
NTLAIntellia Therapeutics--
CRBUCaribou Biosciences--
VERVVerve Therapeutics--
ALLOAllogene Therapeutics--
EDITEditas Medicine--
PRMEPrime Medicine--
SANASana Bio--

EDIT Revenue FAQ

What is Editas Medicine’s yearly revenue?

Editas Medicine's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $19.71M, representing a decrease of -22.83% compared to 2021. EDIT's yearly revenue for 2021 was $25.54M, representing a decrease of -71.85% compared to 2020.

What is Editas Medicine’s quarterly revenue?

Editas Medicine's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $513K, a -54.80% decrease from the previous quarter (Q1 2024), and a -82.23% decrease year-over-year (Q2 2023). EDIT's quarterly revenue for Q1 2024 was $1.14M, a -98.11% decrease from the previous quarter (Q4 2023), and a -88.48% decrease year-over-year (Q1 2023).

What is Editas Medicine’s revenue growth rate?

Editas Medicine's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was -100.00%.